TRV GP V, LLC — Q1 2026 13F-HR

← TRV GP V, LLC

Q1 2026 · 13F-HR

TRV GP V, LLCholdings as filed

Filed 2026-05-07 · accession 0001193125-26-212010

$401.0M

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · TRV GP V, LLC · Q1 2026

AI · grounded in 13F

TRV GP V, LLC reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
75383L102	RAPP	RAPPORT THERAPEUTICS, INC.	$223.3M	55.7%	7,135,233	Common	SOLE
81734D104	SEPN	SEPTERNA, INC.	$149.4M	37.2%	6,215,591	Common	SOLE
578784100	MAZE	MAZE THERAPEUTICS, INC.	$28.4M	7.08%	950,800	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.